Scientific Reports (Mar 2022)

Reduced levels of pulmonary surfactant in COVID-19 ARDS

  • Peter Schousboe,
  • Andreas Ronit,
  • Henning B. Nielsen,
  • Thomas Benfield,
  • Lothar Wiese,
  • Nikolaos Scoutaris,
  • Henrik Verder,
  • Ronan M. G. Berg,
  • Povl Verder,
  • Ronni R. Plovsing

DOI
https://doi.org/10.1038/s41598-022-07944-4
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 5

Abstract

Read online

Abstract To provide novel data on surfactant levels in adult COVID-19 patients, we collected bronchoalveolar lavage fluid less than 72 h after intubation and used Fourier Transform Infrared Spectroscopy to measure levels of dipalmitoylphosphatidylcholine (DPPC). A total of eleven COVID-19 patients with moderate-to-severe ARDS (CARDS) and 15 healthy controls were included. CARDS patients had lower DPPC levels than healthy controls. Moreover, a principal component analysis was able to separate patient groups into distinguishable subgroups. Our findings indicate markedly impaired pulmonary surfactant levels in COVID-19 patients, justifying further studies and clinical trials of exogenous surfactant.